- Home
- TLF vs IMTX Comparison
TLF vs IMTX Comparison
Compare TLF & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLF
- IMTX
- Stock Information
- Founded
- TLF 1980
- IMTX N/A
- Country
- TLF United States
- IMTX Germany
- Employees
- TLF N/A
- IMTX 423
- Industry
- TLF Apparel
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TLF Consumer Discretionary
- IMTX Health Care
- Exchange
- TLF Nasdaq
- IMTX Nasdaq
- Market Cap
- TLF N/A
- IMTX 466.8M
- IPO Year
- TLF N/A
- IMTX N/A
- Fundamental
- Price
- TLF $2.89
- IMTX $3.43
- Analyst Decision
- TLF
- IMTX Strong Buy
- Analyst Count
- TLF 0
- IMTX 4
- Target Price
- TLF N/A
- IMTX $16.67
- AVG Volume (30 Days)
- TLF 16.2K
- IMTX 777.1K
- Earning Date
- TLF 05-09-2025
- IMTX 05-13-2025
- Dividend Yield
- TLF N/A
- IMTX N/A
- EPS Growth
- TLF N/A
- IMTX N/A
- EPS
- TLF 0.09
- IMTX 0.14
- Revenue
- TLF $74,391,000.00
- IMTX $161,336,577.00
- Revenue This Year
- TLF N/A
- IMTX N/A
- Revenue Next Year
- TLF N/A
- IMTX $2.63
- P/E Ratio
- TLF $32.78
- IMTX $26.67
- Revenue Growth
- TLF N/A
- IMTX 188.60
- 52 Week Low
- TLF $2.83
- IMTX $3.83
- 52 Week High
- TLF $5.48
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- TLF 31.61
- IMTX 31.63
- Support Level
- TLF $2.90
- IMTX $4.46
- Resistance Level
- TLF $3.06
- IMTX $4.26
- Average True Range (ATR)
- TLF 0.10
- IMTX 0.38
- MACD
- TLF 0.05
- IMTX -0.10
- Stochastic Oscillator
- TLF 22.58
- IMTX 0.52
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.